Volume 8 Issue 76
Published - 14:00 UTC 08:00 EST 17-Mar-2006 
Next Update - 14:00 UTC 08:00 EST 18-Mar-2006

Editor: Susan K. Boyer, RN
© Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.



Dangers of stopping clopidogrel (Plavix®) for patients with stents and certain other conditions

Recent media reports regarding the results of the CHARISMA Trial may be misinterpreted by patients with coronary stents and other conditions*, causing these patients to inappropriately stop taking the anti-clotting drug clopidogrel (Plavix®). Patients taking Plavix® for any reason should consult with their cardiologist or other health care provider before stopping this medication. more  

Newspaper coverage of neurologic conditions incorrect 20 percent of the time, study shows

Twenty percent of all examined newspaper articles about common neurologic conditions had medical errors or exaggerations, according to a study partnering Mayo Clinic physicians and school of journalism experts from Arizona State University. more

Grieving parents at increased suicide risk

Parents who have cared for a dying child at home may be at higher risk of suicide after the child dies, by overdosing on the powerful painkillers used to ease the child's condition, say two papers in this week's BMJ. more  

Same genes may underlie alcohol and nicotine co-abuse

Vulnerability to both alcohol and nicotine abuse may be influenced by the same genetic factor, according to a recent study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH). more

Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes  

Ginseng, one of the most widely used herbs in traditional Chinese medicine, may improve survival and quality of life after a diagnosis of breast cancer, according to a recent study by Vanderbilt-Ingram Cancer Center researchers. more

Combining multiple treatments improves multiple sclerosis therapy  

Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system (CNS) in which white blood cells known as lymphocytes attack the myelin insulation on nerves in the spinal cord and brain. Glatiramer acetate (GA) is a drug currently approved for MS treatment, but new therapies are needed to improve effectiveness and reduce side effects. more

Neuroscientists discover new cell type that may help brain maintain memories of smells

Neuroscientists at Case Western Reserve University School of Medicine have discovered a new cell type in the part of the brain that processes our sense of smell. This new cell type, the Blanes cell, is a member of a group of previously unstudied brain cells described by the Spanish neuroanatomist Blanes (pronounced blon – es) in the late 1800s. Blanes cells have unusual properties which may help the brain maintain memories of smells and also opens a new approach to understanding the basis of memory impairments in Alzheimer's disease. more


Ginseng may improve survival and quality of life after a diagnosis of breast cancer.